Skip to main content

Shalby Ltd

Stage 4 · Declining · week 9

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. More about the company

₹134.6
-1.38% today
₹1,447 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dHospitals & Diagnostic Centres 29.0%-12.9 pts
Loading price chart…
vs 52W High
-49.4%
₹126.8 lo₹266.3 hi
49.4% below 52W high — deep Stage 4 damage
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 9
1w13w26w
Week 9 — established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-17.2%
200 DMA: ₹162.6 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.40x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↓
MA20 rolling over · -4.7% vs MA50 -6.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-11.8%
3M
-20.0%
6M
-6.8%
YTD
-33.7%
1Y
-46.0%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
Sector has 77 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
29.0%
20d Δ
-12.9pp
1M return
-7.5%
3M return
-8.6%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 33w
S4 47w
S4 18w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 33w → S3 10w → S4 4w → S1 13w → S4 47w → S1 7w → S2 11w → S3 6w → S4 18w → S1 11w → S4 8w current
Total tracked: 169 weeks across 11 stage runs.
Scan Membership
Breakout Watch
Latest: 2025-09-18
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S4
Wk 9 · Vol 0.40x
2026-10-06S4
Wk 8 · Vol 0.55x
2026-10-05S4
Wk 8 · Vol 0.39x
2026-10-01S4
Wk 8 · Vol 2.41x
2026-09-30S4
Wk 8 · Vol 3.14x
2026-09-29S4
Wk 8 · Vol 0.67x
2026-09-28S4
Wk 7 · Vol 0.79x
2026-09-25S4
Wk 7 · Vol 1.27x
2026-09-24S4
Wk 7 · Vol 1.44x
2026-09-23S4
Wk 7 · Vol 2.81x
2026-09-22S4
Wk 7 · Vol 2.54x
2026-09-21S4
Wk 6 · Vol 1.36x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹150.4
200 DMA
₹162.6
52W High
₹266.3
52W Low
₹126.8
5D Low
₹133.6
Resistance levels (recent highs)
20d High
₹149.8
60d High
₹168.2
120d High
₹176.8
250d High
₹266.3
Next resistance
+11.3%
to 20d High
P/E (TTM)
220.9
Forward 18.3
About this companyHealth Care· Hospitals & Diagnostic Centres

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.